Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

Cell Death Dis. 2022 Aug 3;13(8):672. doi: 10.1038/s41419-022-05130-y.

Sophia Ceder¹, Sofi E Eriksson¹, Ying Yu Liang^{1

2}, Emarndeena H Cheteh¹, Si Min Zhang³, Kenji M Fujihara^{4

5}, Julie Bianchi¹, Vladimir J N Bykov¹, Lars Abrahmsen⁶, Nicholas J Clemons^{4

5}, Pär Nordlund^{1

2}, Sean G Rudd³, Klas G Wiman⁷

¹ Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden.
² Institute of Molecular and Cellular Biology, A*STAR, Singapore, Singapore.
³ Science For Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
⁴ Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
⁵ Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
⁶ Aprea Therapeutics AB, Solna, Sweden.
⁷ Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden. [email protected].

No abstract available

Publication types